CD19 and neoplasm: In particular, a highly significant fourfold decrease in CD19+ and CD19+B220low B cell subpopulations was detected in LmAIO-vaccinated animals protected from HCC development in comparison with those in the PBS control group, indicating the tumor-promoting role of B cells in HCC.13